nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrochlorothiazide—Photosensitivity—Doxorubicin—liver cancer	0.00285	0.00301	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Sorafenib—liver cancer	0.00284	0.00301	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Sorafenib—liver cancer	0.00284	0.00301	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Epirubicin—liver cancer	0.00284	0.00301	CcSEcCtD
Hydrochlorothiazide—Purpura—Epirubicin—liver cancer	0.0028	0.00297	CcSEcCtD
Hydrochlorothiazide—Vascular purpura—Doxorubicin—liver cancer	0.00279	0.00296	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Epirubicin—liver cancer	0.00271	0.00287	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Epirubicin—liver cancer	0.0027	0.00286	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.0027	0.00286	CcSEcCtD
Hydrochlorothiazide—Hot flush—Doxorubicin—liver cancer	0.00267	0.00283	CcSEcCtD
Hydrochlorothiazide—Increased appetite—Doxorubicin—liver cancer	0.00266	0.00282	CcSEcCtD
Hydrochlorothiazide—Migraine—Epirubicin—liver cancer	0.00266	0.00282	CcSEcCtD
Hydrochlorothiazide—Affect lability—Epirubicin—liver cancer	0.00266	0.00282	CcSEcCtD
Hydrochlorothiazide—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00265	0.00281	CcSEcCtD
Hydrochlorothiazide—Menopausal symptoms—Doxorubicin—liver cancer	0.00265	0.00281	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Sorafenib—liver cancer	0.00265	0.0028	CcSEcCtD
Hydrochlorothiazide—Renal impairment—Doxorubicin—liver cancer	0.00263	0.00278	CcSEcCtD
Hydrochlorothiazide—Face oedema—Epirubicin—liver cancer	0.00261	0.00276	CcSEcCtD
Hydrochlorothiazide—Purpura—Doxorubicin—liver cancer	0.00259	0.00275	CcSEcCtD
Hydrochlorothiazide—Asthenia—Sorafenib—liver cancer	0.00258	0.00273	CcSEcCtD
Hydrochlorothiazide—Mood swings—Epirubicin—liver cancer	0.00256	0.00271	CcSEcCtD
Hydrochlorothiazide—Pruritus—Sorafenib—liver cancer	0.00254	0.00269	CcSEcCtD
Hydrochlorothiazide—Ataxia—Epirubicin—liver cancer	0.00254	0.00269	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Epirubicin—liver cancer	0.00253	0.00268	CcSEcCtD
Hydrochlorothiazide—Hyponatraemia—Doxorubicin—liver cancer	0.00251	0.00266	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.0025	0.00265	CcSEcCtD
Hydrochlorothiazide—Pain in extremity—Doxorubicin—liver cancer	0.0025	0.00265	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Epirubicin—liver cancer	0.00249	0.00264	CcSEcCtD
Hydrochlorothiazide—Dry skin—Epirubicin—liver cancer	0.00248	0.00262	CcSEcCtD
Hydrochlorothiazide—Abdominal pain upper—Epirubicin—liver cancer	0.00247	0.00261	CcSEcCtD
Hydrochlorothiazide—Orthostatic hypotension—Epirubicin—liver cancer	0.00247	0.00261	CcSEcCtD
Hydrochlorothiazide—Affect lability—Doxorubicin—liver cancer	0.00246	0.00261	CcSEcCtD
Hydrochlorothiazide—Migraine—Doxorubicin—liver cancer	0.00246	0.00261	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Epirubicin—liver cancer	0.00246	0.0026	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Sorafenib—liver cancer	0.00246	0.0026	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Epirubicin—liver cancer	0.00244	0.00258	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00243	0.00258	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00243	0.00258	CcSEcCtD
Hydrochlorothiazide—Face oedema—Doxorubicin—liver cancer	0.00241	0.00256	CcSEcCtD
Hydrochlorothiazide—Gastritis—Epirubicin—liver cancer	0.00239	0.00253	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Epirubicin—liver cancer	0.00238	0.00252	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00238	0.00252	CcSEcCtD
Hydrochlorothiazide—Dizziness—Sorafenib—liver cancer	0.00237	0.00252	CcSEcCtD
Hydrochlorothiazide—Mood swings—Doxorubicin—liver cancer	0.00237	0.00251	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Epirubicin—liver cancer	0.00235	0.00249	CcSEcCtD
Hydrochlorothiazide—Ataxia—Doxorubicin—liver cancer	0.00235	0.00249	CcSEcCtD
Hydrochlorothiazide—Blood creatinine increased—Doxorubicin—liver cancer	0.00234	0.00248	CcSEcCtD
Hydrochlorothiazide—Influenza—Epirubicin—liver cancer	0.00233	0.00247	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Epirubicin—liver cancer	0.00233	0.00247	CcSEcCtD
Hydrochlorothiazide—Liver function test abnormal—Doxorubicin—liver cancer	0.00231	0.00244	CcSEcCtD
Hydrochlorothiazide—Dry skin—Doxorubicin—liver cancer	0.00229	0.00243	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Epirubicin—liver cancer	0.00229	0.00242	CcSEcCtD
Hydrochlorothiazide—Vomiting—Sorafenib—liver cancer	0.00228	0.00242	CcSEcCtD
Hydrochlorothiazide—Abdominal pain upper—Doxorubicin—liver cancer	0.00228	0.00242	CcSEcCtD
Hydrochlorothiazide—Orthostatic hypotension—Doxorubicin—liver cancer	0.00228	0.00242	CcSEcCtD
Hydrochlorothiazide—Hypokalaemia—Doxorubicin—liver cancer	0.00227	0.00241	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Epirubicin—liver cancer	0.00227	0.00241	CcSEcCtD
Hydrochlorothiazide—Rash—Sorafenib—liver cancer	0.00226	0.0024	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Sorafenib—liver cancer	0.00226	0.0024	CcSEcCtD
Hydrochlorothiazide—Breast disorder—Doxorubicin—liver cancer	0.00226	0.00239	CcSEcCtD
Hydrochlorothiazide—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00225	0.00238	CcSEcCtD
Hydrochlorothiazide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00225	0.00238	CcSEcCtD
Hydrochlorothiazide—Headache—Sorafenib—liver cancer	0.00225	0.00238	CcSEcCtD
Hydrochlorothiazide—Gastritis—Doxorubicin—liver cancer	0.00221	0.00234	CcSEcCtD
Hydrochlorothiazide—Muscular weakness—Doxorubicin—liver cancer	0.0022	0.00233	CcSEcCtD
Hydrochlorothiazide—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.0022	0.00233	CcSEcCtD
Hydrochlorothiazide—Dysuria—Epirubicin—liver cancer	0.00218	0.00231	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Epirubicin—liver cancer	0.00218	0.00231	CcSEcCtD
Hydrochlorothiazide—Abdominal distension—Doxorubicin—liver cancer	0.00217	0.0023	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Epirubicin—liver cancer	0.00217	0.0023	CcSEcCtD
Hydrochlorothiazide—Influenza—Doxorubicin—liver cancer	0.00216	0.00229	CcSEcCtD
Hydrochlorothiazide—Dysphagia—Doxorubicin—liver cancer	0.00216	0.00229	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Epirubicin—liver cancer	0.00216	0.00228	CcSEcCtD
Hydrochlorothiazide—Nausea—Sorafenib—liver cancer	0.00213	0.00226	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Epirubicin—liver cancer	0.00213	0.00226	CcSEcCtD
Hydrochlorothiazide—Weight increased—Epirubicin—liver cancer	0.00212	0.00225	CcSEcCtD
Hydrochlorothiazide—Pancreatitis—Doxorubicin—liver cancer	0.00212	0.00224	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Epirubicin—liver cancer	0.00211	0.00223	CcSEcCtD
Hydrochlorothiazide—Angina pectoris—Doxorubicin—liver cancer	0.0021	0.00223	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Epirubicin—liver cancer	0.00209	0.00222	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00206	0.00219	CcSEcCtD
Hydrochlorothiazide—Renal failure—Epirubicin—liver cancer	0.00205	0.00217	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Epirubicin—liver cancer	0.00204	0.00216	CcSEcCtD
Hydrochlorothiazide—Jaundice—Epirubicin—liver cancer	0.00203	0.00215	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Epirubicin—liver cancer	0.00202	0.00214	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Epirubicin—liver cancer	0.00202	0.00214	CcSEcCtD
Hydrochlorothiazide—Dysuria—Doxorubicin—liver cancer	0.00202	0.00214	CcSEcCtD
Hydrochlorothiazide—Neutropenia—Doxorubicin—liver cancer	0.00202	0.00214	CcSEcCtD
Hydrochlorothiazide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00201	0.00213	CcSEcCtD
Hydrochlorothiazide—Sweating—Epirubicin—liver cancer	0.002	0.00211	CcSEcCtD
Hydrochlorothiazide—Pollakiuria—Doxorubicin—liver cancer	0.00199	0.00211	CcSEcCtD
Hydrochlorothiazide—Haematuria—Epirubicin—liver cancer	0.00198	0.0021	CcSEcCtD
Hydrochlorothiazide—Photosensitivity reaction—Doxorubicin—liver cancer	0.00197	0.00209	CcSEcCtD
Hydrochlorothiazide—Weight increased—Doxorubicin—liver cancer	0.00197	0.00208	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Epirubicin—liver cancer	0.00196	0.00208	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Epirubicin—liver cancer	0.00195	0.00207	CcSEcCtD
Hydrochlorothiazide—Hyperglycaemia—Doxorubicin—liver cancer	0.00195	0.00206	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Epirubicin—liver cancer	0.00194	0.00206	CcSEcCtD
Hydrochlorothiazide—Pneumonia—Doxorubicin—liver cancer	0.00194	0.00205	CcSEcCtD
Hydrochlorothiazide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00191	0.00202	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Epirubicin—liver cancer	0.0019	0.00201	CcSEcCtD
Hydrochlorothiazide—Renal failure—Doxorubicin—liver cancer	0.00189	0.00201	CcSEcCtD
Hydrochlorothiazide—Neuropathy peripheral—Doxorubicin—liver cancer	0.00189	0.002	CcSEcCtD
Hydrochlorothiazide—Jaundice—Doxorubicin—liver cancer	0.00188	0.00199	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Epirubicin—liver cancer	0.00187	0.00198	CcSEcCtD
Hydrochlorothiazide—Conjunctivitis—Doxorubicin—liver cancer	0.00187	0.00198	CcSEcCtD
Hydrochlorothiazide—Urinary tract infection—Doxorubicin—liver cancer	0.00187	0.00198	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Epirubicin—liver cancer	0.00187	0.00198	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Epirubicin—liver cancer	0.00186	0.00197	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Epirubicin—liver cancer	0.00185	0.00196	CcSEcCtD
Hydrochlorothiazide—Sweating—Doxorubicin—liver cancer	0.00185	0.00196	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Epirubicin—liver cancer	0.00184	0.00195	CcSEcCtD
Hydrochlorothiazide—Haematuria—Doxorubicin—liver cancer	0.00184	0.00194	CcSEcCtD
Hydrochlorothiazide—Epistaxis—Doxorubicin—liver cancer	0.00182	0.00192	CcSEcCtD
Hydrochlorothiazide—Sinusitis—Doxorubicin—liver cancer	0.00181	0.00191	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Epirubicin—liver cancer	0.0018	0.00191	CcSEcCtD
Hydrochlorothiazide—Agranulocytosis—Doxorubicin—liver cancer	0.0018	0.0019	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Epirubicin—liver cancer	0.00177	0.00187	CcSEcCtD
Hydrochlorothiazide—Bradycardia—Doxorubicin—liver cancer	0.00176	0.00186	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Epirubicin—liver cancer	0.00174	0.00185	CcSEcCtD
Hydrochlorothiazide—Flushing—Epirubicin—liver cancer	0.00173	0.00184	CcSEcCtD
Hydrochlorothiazide—Rhinitis—Doxorubicin—liver cancer	0.00173	0.00184	CcSEcCtD
Hydrochlorothiazide—Hepatitis—Doxorubicin—liver cancer	0.00173	0.00183	CcSEcCtD
Hydrochlorothiazide—Hypoaesthesia—Doxorubicin—liver cancer	0.00172	0.00182	CcSEcCtD
Hydrochlorothiazide—Pharyngitis—Doxorubicin—liver cancer	0.00172	0.00182	CcSEcCtD
Hydrochlorothiazide—Oedema peripheral—Doxorubicin—liver cancer	0.0017	0.0018	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Epirubicin—liver cancer	0.00167	0.00177	CcSEcCtD
Hydrochlorothiazide—Visual impairment—Doxorubicin—liver cancer	0.00167	0.00176	CcSEcCtD
Hydrochlorothiazide—Alopecia—Epirubicin—liver cancer	0.00165	0.00175	CcSEcCtD
Hydrochlorothiazide—Erythema multiforme—Doxorubicin—liver cancer	0.00163	0.00173	CcSEcCtD
Hydrochlorothiazide—Erythema—Epirubicin—liver cancer	0.00163	0.00172	CcSEcCtD
Hydrochlorothiazide—Tinnitus—Doxorubicin—liver cancer	0.00161	0.00171	CcSEcCtD
Hydrochlorothiazide—Flushing—Doxorubicin—liver cancer	0.0016	0.0017	CcSEcCtD
Hydrochlorothiazide—Flatulence—Epirubicin—liver cancer	0.0016	0.0017	CcSEcCtD
Hydrochlorothiazide—Tension—Epirubicin—liver cancer	0.0016	0.00169	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Epirubicin—liver cancer	0.00159	0.00169	CcSEcCtD
Hydrochlorothiazide—Nervousness—Epirubicin—liver cancer	0.00158	0.00167	CcSEcCtD
Hydrochlorothiazide—Back pain—Epirubicin—liver cancer	0.00157	0.00167	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Epirubicin—liver cancer	0.00156	0.00166	CcSEcCtD
Hydrochlorothiazide—Arrhythmia—Doxorubicin—liver cancer	0.00154	0.00164	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Epirubicin—liver cancer	0.00153	0.00162	CcSEcCtD
Hydrochlorothiazide—Alopecia—Doxorubicin—liver cancer	0.00153	0.00162	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Epirubicin—liver cancer	0.00151	0.0016	CcSEcCtD
Hydrochlorothiazide—Erythema—Doxorubicin—liver cancer	0.0015	0.00159	CcSEcCtD
Hydrochlorothiazide—Anaemia—Epirubicin—liver cancer	0.0015	0.00159	CcSEcCtD
Hydrochlorothiazide—Agitation—Epirubicin—liver cancer	0.00149	0.00158	CcSEcCtD
Hydrochlorothiazide—Flatulence—Doxorubicin—liver cancer	0.00148	0.00157	CcSEcCtD
Hydrochlorothiazide—Tension—Doxorubicin—liver cancer	0.00148	0.00156	CcSEcCtD
Hydrochlorothiazide—Dysgeusia—Doxorubicin—liver cancer	0.00147	0.00156	CcSEcCtD
Hydrochlorothiazide—Malaise—Epirubicin—liver cancer	0.00147	0.00155	CcSEcCtD
Hydrochlorothiazide—Nervousness—Doxorubicin—liver cancer	0.00146	0.00155	CcSEcCtD
Hydrochlorothiazide—Vertigo—Epirubicin—liver cancer	0.00146	0.00155	CcSEcCtD
Hydrochlorothiazide—Syncope—Epirubicin—liver cancer	0.00146	0.00154	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Epirubicin—liver cancer	0.00146	0.00154	CcSEcCtD
Hydrochlorothiazide—Back pain—Doxorubicin—liver cancer	0.00146	0.00154	CcSEcCtD
Hydrochlorothiazide—Muscle spasms—Doxorubicin—liver cancer	0.00145	0.00153	CcSEcCtD
Hydrochlorothiazide—Palpitations—Epirubicin—liver cancer	0.00144	0.00152	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Epirubicin—liver cancer	0.00143	0.00151	CcSEcCtD
Hydrochlorothiazide—Cough—Epirubicin—liver cancer	0.00142	0.0015	CcSEcCtD
Hydrochlorothiazide—Vision blurred—Doxorubicin—liver cancer	0.00142	0.0015	CcSEcCtD
Hydrochlorothiazide—Ill-defined disorder—Doxorubicin—liver cancer	0.0014	0.00148	CcSEcCtD
Hydrochlorothiazide—Anaemia—Doxorubicin—liver cancer	0.00139	0.00147	CcSEcCtD
Hydrochlorothiazide—Chest pain—Epirubicin—liver cancer	0.00138	0.00147	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Epirubicin—liver cancer	0.00138	0.00147	CcSEcCtD
Hydrochlorothiazide—Myalgia—Epirubicin—liver cancer	0.00138	0.00147	CcSEcCtD
Hydrochlorothiazide—Agitation—Doxorubicin—liver cancer	0.00138	0.00146	CcSEcCtD
Hydrochlorothiazide—Anxiety—Epirubicin—liver cancer	0.00138	0.00146	CcSEcCtD
Hydrochlorothiazide—Discomfort—Epirubicin—liver cancer	0.00137	0.00145	CcSEcCtD
Hydrochlorothiazide—Malaise—Doxorubicin—liver cancer	0.00136	0.00144	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Epirubicin—liver cancer	0.00135	0.00143	CcSEcCtD
Hydrochlorothiazide—Vertigo—Doxorubicin—liver cancer	0.00135	0.00143	CcSEcCtD
Hydrochlorothiazide—Syncope—Doxorubicin—liver cancer	0.00135	0.00143	CcSEcCtD
Hydrochlorothiazide—Leukopenia—Doxorubicin—liver cancer	0.00135	0.00143	CcSEcCtD
Hydrochlorothiazide—Confusional state—Epirubicin—liver cancer	0.00134	0.00142	CcSEcCtD
Hydrochlorothiazide—Palpitations—Doxorubicin—liver cancer	0.00133	0.00141	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Epirubicin—liver cancer	0.00133	0.00141	CcSEcCtD
Hydrochlorothiazide—Oedema—Epirubicin—liver cancer	0.00133	0.00141	CcSEcCtD
Hydrochlorothiazide—Loss of consciousness—Doxorubicin—liver cancer	0.00132	0.0014	CcSEcCtD
Hydrochlorothiazide—Cough—Doxorubicin—liver cancer	0.00131	0.00139	CcSEcCtD
Hydrochlorothiazide—Shock—Epirubicin—liver cancer	0.00131	0.00138	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Epirubicin—liver cancer	0.0013	0.00138	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Epirubicin—liver cancer	0.0013	0.00137	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Epirubicin—liver cancer	0.00128	0.00136	CcSEcCtD
Hydrochlorothiazide—Myalgia—Doxorubicin—liver cancer	0.00128	0.00136	CcSEcCtD
Hydrochlorothiazide—Chest pain—Doxorubicin—liver cancer	0.00128	0.00136	CcSEcCtD
Hydrochlorothiazide—Arthralgia—Doxorubicin—liver cancer	0.00128	0.00136	CcSEcCtD
Hydrochlorothiazide—Anxiety—Doxorubicin—liver cancer	0.00128	0.00135	CcSEcCtD
Hydrochlorothiazide—Discomfort—Doxorubicin—liver cancer	0.00127	0.00134	CcSEcCtD
Hydrochlorothiazide—Anorexia—Epirubicin—liver cancer	0.00127	0.00134	CcSEcCtD
Hydrochlorothiazide—Dry mouth—Doxorubicin—liver cancer	0.00125	0.00133	CcSEcCtD
Hydrochlorothiazide—Hypotension—Epirubicin—liver cancer	0.00124	0.00131	CcSEcCtD
Hydrochlorothiazide—Confusional state—Doxorubicin—liver cancer	0.00124	0.00131	CcSEcCtD
Hydrochlorothiazide—Anaphylactic shock—Doxorubicin—liver cancer	0.00123	0.0013	CcSEcCtD
Hydrochlorothiazide—Oedema—Doxorubicin—liver cancer	0.00123	0.0013	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00121	0.00128	CcSEcCtD
Hydrochlorothiazide—Shock—Doxorubicin—liver cancer	0.00121	0.00128	CcSEcCtD
Hydrochlorothiazide—Thrombocytopenia—Doxorubicin—liver cancer	0.0012	0.00127	CcSEcCtD
Hydrochlorothiazide—Insomnia—Epirubicin—liver cancer	0.0012	0.00127	CcSEcCtD
Hydrochlorothiazide—Tachycardia—Doxorubicin—liver cancer	0.0012	0.00127	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Epirubicin—liver cancer	0.00119	0.00126	CcSEcCtD
Hydrochlorothiazide—Hyperhidrosis—Doxorubicin—liver cancer	0.00119	0.00126	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Epirubicin—liver cancer	0.00118	0.00125	CcSEcCtD
Hydrochlorothiazide—Somnolence—Epirubicin—liver cancer	0.00118	0.00125	CcSEcCtD
Hydrochlorothiazide—Anorexia—Doxorubicin—liver cancer	0.00117	0.00124	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Epirubicin—liver cancer	0.00117	0.00124	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Epirubicin—liver cancer	0.00115	0.00122	CcSEcCtD
Hydrochlorothiazide—Hypotension—Doxorubicin—liver cancer	0.00115	0.00122	CcSEcCtD
Hydrochlorothiazide—Fatigue—Epirubicin—liver cancer	0.00114	0.00121	CcSEcCtD
Hydrochlorothiazide—Pain—Epirubicin—liver cancer	0.00113	0.0012	CcSEcCtD
Hydrochlorothiazide—Constipation—Epirubicin—liver cancer	0.00113	0.0012	CcSEcCtD
Hydrochlorothiazide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00112	0.00119	CcSEcCtD
Hydrochlorothiazide—Insomnia—Doxorubicin—liver cancer	0.00111	0.00118	CcSEcCtD
Hydrochlorothiazide—Paraesthesia—Doxorubicin—liver cancer	0.0011	0.00117	CcSEcCtD
Hydrochlorothiazide—Dyspnoea—Doxorubicin—liver cancer	0.00109	0.00116	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Epirubicin—liver cancer	0.00109	0.00116	CcSEcCtD
Hydrochlorothiazide—Somnolence—Doxorubicin—liver cancer	0.00109	0.00116	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Epirubicin—liver cancer	0.00109	0.00115	CcSEcCtD
Hydrochlorothiazide—Dyspepsia—Doxorubicin—liver cancer	0.00108	0.00115	CcSEcCtD
Hydrochlorothiazide—Decreased appetite—Doxorubicin—liver cancer	0.00107	0.00113	CcSEcCtD
Hydrochlorothiazide—Fatigue—Doxorubicin—liver cancer	0.00106	0.00112	CcSEcCtD
Hydrochlorothiazide—Urticaria—Epirubicin—liver cancer	0.00105	0.00112	CcSEcCtD
Hydrochlorothiazide—Pain—Doxorubicin—liver cancer	0.00105	0.00111	CcSEcCtD
Hydrochlorothiazide—Constipation—Doxorubicin—liver cancer	0.00105	0.00111	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Epirubicin—liver cancer	0.00105	0.00111	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Epirubicin—liver cancer	0.00105	0.00111	CcSEcCtD
Hydrochlorothiazide—Feeling abnormal—Doxorubicin—liver cancer	0.00101	0.00107	CcSEcCtD
Hydrochlorothiazide—Gastrointestinal pain—Doxorubicin—liver cancer	0.001	0.00106	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Epirubicin—liver cancer	0.000978	0.00104	CcSEcCtD
Hydrochlorothiazide—Urticaria—Doxorubicin—liver cancer	0.000976	0.00103	CcSEcCtD
Hydrochlorothiazide—Abdominal pain—Doxorubicin—liver cancer	0.000971	0.00103	CcSEcCtD
Hydrochlorothiazide—Body temperature increased—Doxorubicin—liver cancer	0.000971	0.00103	CcSEcCtD
Hydrochlorothiazide—Asthenia—Epirubicin—liver cancer	0.000952	0.00101	CcSEcCtD
Hydrochlorothiazide—Pruritus—Epirubicin—liver cancer	0.000939	0.000995	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Epirubicin—liver cancer	0.000908	0.000962	CcSEcCtD
Hydrochlorothiazide—Hypersensitivity—Doxorubicin—liver cancer	0.000905	0.000958	CcSEcCtD
Hydrochlorothiazide—Asthenia—Doxorubicin—liver cancer	0.000881	0.000933	CcSEcCtD
Hydrochlorothiazide—Dizziness—Epirubicin—liver cancer	0.000878	0.00093	CcSEcCtD
Hydrochlorothiazide—Pruritus—Doxorubicin—liver cancer	0.000869	0.00092	CcSEcCtD
Hydrochlorothiazide—Vomiting—Epirubicin—liver cancer	0.000844	0.000894	CcSEcCtD
Hydrochlorothiazide—Diarrhoea—Doxorubicin—liver cancer	0.00084	0.00089	CcSEcCtD
Hydrochlorothiazide—Rash—Epirubicin—liver cancer	0.000837	0.000886	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Epirubicin—liver cancer	0.000836	0.000886	CcSEcCtD
Hydrochlorothiazide—Headache—Epirubicin—liver cancer	0.000831	0.000881	CcSEcCtD
Hydrochlorothiazide—Dizziness—Doxorubicin—liver cancer	0.000812	0.00086	CcSEcCtD
Hydrochlorothiazide—Nausea—Epirubicin—liver cancer	0.000788	0.000835	CcSEcCtD
Hydrochlorothiazide—Vomiting—Doxorubicin—liver cancer	0.000781	0.000827	CcSEcCtD
Hydrochlorothiazide—Rash—Doxorubicin—liver cancer	0.000774	0.00082	CcSEcCtD
Hydrochlorothiazide—Dermatitis—Doxorubicin—liver cancer	0.000774	0.000819	CcSEcCtD
Hydrochlorothiazide—Headache—Doxorubicin—liver cancer	0.000769	0.000815	CcSEcCtD
Hydrochlorothiazide—Nausea—Doxorubicin—liver cancer	0.000729	0.000773	CcSEcCtD
Hydrochlorothiazide—KCNMA1—Hemostasis—IFNA1—liver cancer	0.000223	0.00397	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CPT1B—liver cancer	0.000221	0.00395	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GLUL—liver cancer	0.000221	0.00395	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—TAT—liver cancer	0.000221	0.00394	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—UGDH—liver cancer	0.000218	0.00389	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NR1H4—liver cancer	0.000213	0.0038	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—H2AFX—liver cancer	0.000212	0.00379	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTA3—liver cancer	0.000209	0.00374	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—EPT1—liver cancer	0.000205	0.00366	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GLUL—liver cancer	0.000205	0.00366	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CPT1B—liver cancer	0.000205	0.00366	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—liver cancer	0.000204	0.00364	CbGpPWpGaD
Hydrochlorothiazide—CA1—C-MYB transcription factor network—HRAS—liver cancer	0.000199	0.00355	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000199	0.00355	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—BRAF—liver cancer	0.000198	0.00353	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NR1H4—liver cancer	0.000197	0.00352	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PRKCE—liver cancer	0.000197	0.00352	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—TAT—liver cancer	0.000194	0.00347	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTA3—liver cancer	0.000194	0.00347	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTA4—liver cancer	0.000192	0.00342	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000188	0.00336	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—JUN—liver cancer	0.000187	0.00335	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—ABL1—liver cancer	0.000187	0.00335	CbGpPWpGaD
Hydrochlorothiazide—CA9—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000187	0.00334	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTA2—liver cancer	0.000187	0.00333	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IGF2—liver cancer	0.000187	0.00333	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTA1—liver cancer	0.00018	0.00322	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00018	0.00321	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—NAT2—liver cancer	0.000178	0.00318	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTA4—liver cancer	0.000177	0.00317	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—MAPK8—liver cancer	0.000177	0.00317	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HGF—liver cancer	0.000176	0.00315	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—MAPK14—liver cancer	0.000175	0.00312	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—CSF2—liver cancer	0.000174	0.00311	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTA2—liver cancer	0.000173	0.00309	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000173	0.00308	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000172	0.00308	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000172	0.00308	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ALDOB—liver cancer	0.000171	0.00305	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTA1—liver cancer	0.000167	0.00298	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—RAF1—liver cancer	0.000165	0.00295	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—NAT2—liver cancer	0.000165	0.00295	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GLUL—liver cancer	0.000163	0.00292	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CPT1B—liver cancer	0.000163	0.00292	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000163	0.00291	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CRABP1—liver cancer	0.000163	0.00291	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ALDOB—liver cancer	0.000158	0.00282	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NR1H4—liver cancer	0.000157	0.00281	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CPT1B—liver cancer	0.000157	0.00279	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GLUL—liver cancer	0.000157	0.00279	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTA3—liver cancer	0.000155	0.00276	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NR1H4—liver cancer	0.000151	0.00269	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CRABP1—liver cancer	0.000151	0.00269	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CPT1B—liver cancer	0.00015	0.00268	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GLUL—liver cancer	0.00015	0.00268	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTA3—liver cancer	0.000148	0.00265	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NR1H4—liver cancer	0.000145	0.00258	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—HPGDS—liver cancer	0.000142	0.00254	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTA3—liver cancer	0.000142	0.00254	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTA4—liver cancer	0.000142	0.00253	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—MAPK14—liver cancer	0.000141	0.00252	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000139	0.00249	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTA2—liver cancer	0.000138	0.00246	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—F2—liver cancer	0.000137	0.00244	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTA4—liver cancer	0.000136	0.00242	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTA1—liver cancer	0.000133	0.00238	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTA2—liver cancer	0.000132	0.00236	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CPT1B—liver cancer	0.000132	0.00236	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GLUL—liver cancer	0.000132	0.00236	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—HPGDS—liver cancer	0.000132	0.00236	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—NAT2—liver cancer	0.000132	0.00235	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN2A—liver cancer	0.000131	0.00235	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CG—liver cancer	0.000131	0.00234	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTA4—liver cancer	0.00013	0.00232	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTA1—liver cancer	0.000128	0.00228	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NR1H4—liver cancer	0.000127	0.00227	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PSMA4—liver cancer	0.000127	0.00227	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PSMD10—liver cancer	0.000127	0.00227	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTA2—liver cancer	0.000127	0.00226	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—NAT2—liver cancer	0.000126	0.00225	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ALDOB—liver cancer	0.000126	0.00225	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTA3—liver cancer	0.000125	0.00223	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—MTOR—liver cancer	0.000124	0.00221	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—TP53—liver cancer	0.000124	0.00221	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GOT2—liver cancer	0.000123	0.0022	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTA1—liver cancer	0.000122	0.00218	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—NAT2—liver cancer	0.000121	0.00216	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ALDOB—liver cancer	0.000121	0.00216	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CRABP1—liver cancer	0.00012	0.00215	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PSMA4—liver cancer	0.000118	0.0021	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PSMD10—liver cancer	0.000118	0.0021	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN1B—liver cancer	0.000116	0.00208	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP2E1—liver cancer	0.000116	0.00207	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ALDOB—liver cancer	0.000116	0.00207	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CRABP1—liver cancer	0.000115	0.00206	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CD—liver cancer	0.000115	0.00205	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTA4—liver cancer	0.000114	0.00204	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GOT2—liver cancer	0.000114	0.00204	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—SERPINE1—liver cancer	0.000114	0.00203	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—ALB—liver cancer	0.000114	0.00203	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Circadian rythm related genes—IL6—liver cancer	0.000113	0.00202	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTA2—liver cancer	0.000111	0.00199	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—JUN—liver cancer	0.000111	0.00198	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CRABP1—liver cancer	0.000111	0.00198	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYCS—liver cancer	0.000109	0.00194	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTA1—liver cancer	0.000108	0.00192	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP2E1—liver cancer	0.000108	0.00192	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—CDKN1A—liver cancer	0.000107	0.00192	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GOT1—liver cancer	0.000107	0.0019	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GGT1—liver cancer	0.000107	0.0019	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—NAT2—liver cancer	0.000106	0.0019	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—HPGDS—liver cancer	0.000105	0.00188	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—MAPK8—liver cancer	0.000105	0.00187	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—ALB—liver cancer	0.000104	0.00185	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—RAF1—liver cancer	0.000103	0.00183	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ALDOB—liver cancer	0.000102	0.00182	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—HPGDS—liver cancer	0.000101	0.0018	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYCS—liver cancer	0.000101	0.0018	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CB—liver cancer	0.0001	0.00179	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GOT1—liver cancer	9.87e-05	0.00176	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GGT1—liver cancer	9.87e-05	0.00176	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CRABP1—liver cancer	9.73e-05	0.00174	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—VEGFA—liver cancer	9.68e-05	0.00173	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—HPGDS—liver cancer	9.67e-05	0.00173	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—STAT3—liver cancer	9.58e-05	0.00171	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTP1—liver cancer	9.57e-05	0.00171	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—HMOX1—liver cancer	9.44e-05	0.00169	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PSMA4—liver cancer	9.38e-05	0.00167	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PSMD10—liver cancer	9.38e-05	0.00167	CbGpPWpGaD
Hydrochlorothiazide—SLC12A3—Transmembrane transport of small molecules—RAF1—liver cancer	9.37e-05	0.00167	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—IL2—liver cancer	9.2e-05	0.00164	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GOT2—liver cancer	9.12e-05	0.00163	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Neuronal System—HRAS—liver cancer	9.1e-05	0.00162	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PSMA4—liver cancer	8.99e-05	0.00161	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PSMD10—liver cancer	8.99e-05	0.00161	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTP1—liver cancer	8.87e-05	0.00158	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—GSTM1—liver cancer	8.8e-05	0.00157	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—HMOX1—liver cancer	8.75e-05	0.00156	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GOT2—liver cancer	8.74e-05	0.00156	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PSMD10—liver cancer	8.62e-05	0.00154	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PSMA4—liver cancer	8.62e-05	0.00154	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP2E1—liver cancer	8.58e-05	0.00153	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	8.53e-05	0.00152	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—HPGDS—liver cancer	8.5e-05	0.00152	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GOT2—liver cancer	8.38e-05	0.0015	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—CYP1A1—liver cancer	8.34e-05	0.00149	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	8.31e-05	0.00148	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP2E1—liver cancer	8.22e-05	0.00147	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—GSTM1—liver cancer	8.15e-05	0.00146	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYCS—liver cancer	8.02e-05	0.00143	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP2E1—liver cancer	7.88e-05	0.00141	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GGT1—liver cancer	7.87e-05	0.00141	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GOT1—liver cancer	7.87e-05	0.00141	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—VEGFA—liver cancer	7.82e-05	0.0014	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—MTHFR—liver cancer	7.77e-05	0.00139	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—CYP1A1—liver cancer	7.73e-05	0.00138	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYCS—liver cancer	7.69e-05	0.00137	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARA—liver cancer	7.63e-05	0.00136	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PSMA4—liver cancer	7.58e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PSMD10—liver cancer	7.58e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GOT1—liver cancer	7.55e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GGT1—liver cancer	7.55e-05	0.00135	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYCS—liver cancer	7.38e-05	0.00132	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GOT2—liver cancer	7.37e-05	0.00132	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—TP53—liver cancer	7.31e-05	0.00131	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GGT1—liver cancer	7.24e-05	0.00129	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GOT1—liver cancer	7.24e-05	0.00129	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	7.22e-05	0.00129	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—MTHFR—liver cancer	7.2e-05	0.00129	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TGFB1—liver cancer	7.18e-05	0.00128	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTP1—liver cancer	7.07e-05	0.00126	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARA—liver cancer	7.07e-05	0.00126	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—HMOX1—liver cancer	6.97e-05	0.00125	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP2E1—liver cancer	6.93e-05	0.00124	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTP1—liver cancer	6.78e-05	0.00121	CbGpPWpGaD
Hydrochlorothiazide—CA9—Cellular responses to stress—IL6—liver cancer	6.69e-05	0.0012	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—HMOX1—liver cancer	6.69e-05	0.00119	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—KRAS—liver cancer	6.65e-05	0.00119	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CG—liver cancer	6.53e-05	0.00117	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTP1—liver cancer	6.5e-05	0.00116	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—GSTM1—liver cancer	6.5e-05	0.00116	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYCS—liver cancer	6.48e-05	0.00116	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—HMOX1—liver cancer	6.41e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GOT1—liver cancer	6.36e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GGT1—liver cancer	6.36e-05	0.00114	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PPARG—liver cancer	6.3e-05	0.00113	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—GSTM1—liver cancer	6.23e-05	0.00111	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—CYP1A1—liver cancer	6.16e-05	0.0011	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—PIK3CA—liver cancer	6.11e-05	0.00109	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CG—liver cancer	6.05e-05	0.00108	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—GSTM1—liver cancer	5.97e-05	0.00107	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—TP53—liver cancer	5.91e-05	0.00106	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—CYP1A1—liver cancer	5.91e-05	0.00105	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PPARG—liver cancer	5.84e-05	0.00104	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	5.83e-05	0.00104	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—MTHFR—liver cancer	5.74e-05	0.00103	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CD—liver cancer	5.74e-05	0.00103	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTP1—liver cancer	5.71e-05	0.00102	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—ALB—liver cancer	5.67e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—CYP1A1—liver cancer	5.66e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—HRAS—liver cancer	5.65e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—HMOX1—liver cancer	5.64e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARA—liver cancer	5.64e-05	0.00101	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—MTHFR—liver cancer	5.51e-05	0.000983	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARA—liver cancer	5.4e-05	0.000965	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CD—liver cancer	5.32e-05	0.00095	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—MTHFR—liver cancer	5.28e-05	0.000943	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—GSTM1—liver cancer	5.25e-05	0.000938	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—ALB—liver cancer	5.25e-05	0.000938	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARA—liver cancer	5.18e-05	0.000925	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CB—liver cancer	5.01e-05	0.000894	CbGpPWpGaD
Hydrochlorothiazide—KCNMA1—Hemostasis—AKT1—liver cancer	4.99e-05	0.000891	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—CYP1A1—liver cancer	4.98e-05	0.000889	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CG—liver cancer	4.83e-05	0.000862	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PPARG—liver cancer	4.66e-05	0.000832	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—MTHFR—liver cancer	4.64e-05	0.000829	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CB—liver cancer	4.64e-05	0.000828	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CG—liver cancer	4.63e-05	0.000826	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARA—liver cancer	4.55e-05	0.000813	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PPARG—liver cancer	4.47e-05	0.000797	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CG—liver cancer	4.44e-05	0.000792	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	4.33e-05	0.000774	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PPARG—liver cancer	4.28e-05	0.000764	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CD—liver cancer	4.24e-05	0.000758	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—ALB—liver cancer	4.19e-05	0.000748	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CD—liver cancer	4.07e-05	0.000726	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—ALB—liver cancer	4.02e-05	0.000717	CbGpPWpGaD
Hydrochlorothiazide—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	3.92e-05	0.0007	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CG—liver cancer	3.9e-05	0.000696	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CD—liver cancer	3.9e-05	0.000696	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—ALB—liver cancer	3.85e-05	0.000687	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PPARG—liver cancer	3.76e-05	0.000672	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CB—liver cancer	3.7e-05	0.00066	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CB—liver cancer	3.55e-05	0.000633	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CD—liver cancer	3.43e-05	0.000612	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CB—liver cancer	3.4e-05	0.000607	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—ALB—liver cancer	3.38e-05	0.000604	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—PIK3CA—liver cancer	3.05e-05	0.000545	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CB—liver cancer	2.99e-05	0.000534	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—PIK3CA—liver cancer	2.83e-05	0.000505	CbGpPWpGaD
Hydrochlorothiazide—CA5B—Metabolism—AKT1—liver cancer	2.49e-05	0.000445	CbGpPWpGaD
Hydrochlorothiazide—CA12—Metabolism—AKT1—liver cancer	2.31e-05	0.000412	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—PIK3CA—liver cancer	2.25e-05	0.000403	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—PIK3CA—liver cancer	2.16e-05	0.000386	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—PIK3CA—liver cancer	2.07e-05	0.00037	CbGpPWpGaD
Hydrochlorothiazide—CA4—Metabolism—AKT1—liver cancer	1.84e-05	0.000329	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—PIK3CA—liver cancer	1.82e-05	0.000325	CbGpPWpGaD
Hydrochlorothiazide—CA2—Metabolism—AKT1—liver cancer	1.77e-05	0.000315	CbGpPWpGaD
Hydrochlorothiazide—CA1—Metabolism—AKT1—liver cancer	1.69e-05	0.000302	CbGpPWpGaD
Hydrochlorothiazide—CA9—Metabolism—AKT1—liver cancer	1.49e-05	0.000266	CbGpPWpGaD
